
MOASC
@moasc_office
Our mission is to advance and protect the ability of cancer patients to obtain, and oncology physicians to provide, optimal cancer care.
ID: 835884799
http://www.moasc.org 20-09-2012 16:15:55
4,4K Tweet
622 Followers
674 Following

Starting our Los Angeles Cholangiocarcinoma Symposium at USC Norris Comprehensive Cancer Center with the Cholangiocarcinoma Foundation. Patients, caregivers, researchers, clinicians, and advocates gathered together! USC Norris Comprehensive Cancer Center Cholangiocarcinoma Foundation Keck School of Medicine of USC





What are the metabolic links between diabetes, obesity and cancer? How can understanding those connections lead to new ways to prevent and treat multiple diseases? Sumanta K. Pal, MD, FASCO and Charles Brenner, PhD explore these topics on On the Edge of Breakthrough! Watch: bit.ly/4lGtHmX

We are so proud of you Rana McKay, MD, FASCO UC San Diego Health Moores Cancer Center! Keep up the amazing work!

A true legend in the field of hematology/oncology. Dr. Stephen Forman was involved in the seminal studies of BMT for hematologic malignancies & evolved into a pioneer of CAR-T cell therapy. There are literally dozens of faculty at City of Hope & beyond who consider him to be their


In the newest episode of On the Edge of Breakthrough: Voices of Cancer Research, Sumanta K. Pal, MD, FASCO and Dr. Stephen J. Forman discuss decades of progress in bone marrow transplantation, CAR T cell therapy, the human side of innovation and more. Watch: youtu.be/z8WGtTPgQUU

Legend. It's the first word that comes to mind when I think of Stephen J. Forman, MD City of Hope. He made massive contributions to the world of #BMT as the field came into being & continued on to become a pioneer in CAR-T for both liquid & solid tumors. An inspiration to all

Awesome to see Edward S. Kim, MD, MBA, FACP, FASCO City of Hope | Orange County at #BTGlung2025, chaired by Narjust Florez, MD, FASCO Dana-Farber. Hear more about what inspired Dr. Kim in his journey towards a career in #oncology on the City of Hope podcast below 👇donington Tejas Patil Christine Bestvina Balazs Halmos


Stellar presentation by keynote speaker Ashish M. Kamat, MD, MBBS on bladder-sparing options in muscle-invasive disease and nuances of intermediate-risk NMIBC. 🔵 Presented at the 2nd Genitourinary Cancer Research Team @CityofHope City of Hope retreat, made possible by incredible team of physicians led by Wesley Yip


What an amazing keynote presentation from our VP Ashish M. Kamat, MD, MBBS during our @CityofHope Annual GU Research Retreat organized by @MontyPal and Tanya Dorff. A visit full of inspiring discussions for future collaboration over delicious food (can always trust Clayton Lau with the menu)




Proud of MOASC VP Sumanta K. Pal, MD, FASCO who is spotlighted here by Eric J. Small, MD, FASCO for his contributions to the ASCO LDP! Ashkan Mina S. Sedrak Dani Castillo Neal S. Chawla

Just published online in Journal of Clinical Oncology : #SunRISe1 Phase IIb results show TAR-200 (novel intravesical drug releasing system) achieves 82.4% CR in BCG-unresponsive high-risk NMIBC—with durable responses (median DOR 25.8 mo) & low toxicity. A game-changer for pts with #NMIBC.

We win and we fail, we standup and try again… sharing a recent rejection Thanks Stephanie Graff, MD, FACP, FASCO for all the encouragement and Mayo Clinic Comprehensive Cancer Center for support. Fumiko Ladd Chino, MD, FASCO - here is my recent rejection!!! Hem-Onc Fellows Network Hematology & Oncology Women Physicians Group—HOWPG Mayo Clinic Hematology-Oncology Fellowship IMG Oncologists

